AzTrials
AzTrials

Jaw, Edentulous, PartiallyNCT05883202

Effect of the Abutment-Prosthesis Connection on Marginal Bone Loss and Gingival Sealing Around Dental Implants

A study testing Connect® and Multi-unit in people with Jaw, Edentulous, Partially, run by Universidad de Granada at 1 site in Spain.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

In dental implant restoration, available literature demonstrates the advantage of using tall abutments, with a change of diameter with respect to the implant and a conical internal connection in the abutment-implant gap. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Jaw, Edentulous, Partially
What is being tested?
Connect® and Multi-unit
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSpain
Study dates
10 Jul 2023to Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Kennedy class I or II (unilateral or bilateral free end) or III (posterior intermediate edentulous section) mandibular requiring 2 implants to restore at least 2 molars, 2 molars and 1 premolar, or 2 premolars and 1 molar.
  • Possibility of placing a transgingival abutment at least 2 mm high.

Who cannot join

  • Need for simultaneous bone augmentation.
  • Heavy smokers (>10 cigarettes/day).
  • Uncontrolled type 1 or 2 diabetes (HgA1c>8).
  • Known autoimmune or inflammatory disease.
  • Serious blood disorders, such as hemophilia or leukemia.
  • Local or systemic infection that may compromise normal healing (e.g., extensive periapical pathology).
Show all 14Show fewer
  • Liver or kidney dysfunction/failure.
  • Currently receiving cancer treatment or within 18 months from completion of radio- or chemotherapy.
  • Long-term history of oral bisphosphonates use (i.e., 10 years or more).
  • History of intravenous bisphosphonates.
  • Long-term (>3 months) history of antibiotics or drugs known to alter the inflammation and/or immunological system 3 months before inclusion.
  • Severe osseous diseases (e.g., Paget disease of bone).
  • Pregnant women or nursing mothers.
  • Not able or not willing to follow instructions related to the study procedures.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Universidad de Granada

    Granada, Granada, 18071

Other trials in Spain

About this study

In dental implant restoration, available literature demonstrates the advantage of using tall abutments, with a change of diameter with respect to the implant and a conical internal connection in the abutment-implant gap. However, for multiple restorations, the abutment-prosthesis connection has not been studied in detail. The "multi-unit" systems, both standard and brand specific, have either a flat or butt joint or an cone. In any case, both are external connection systems. Recently, an internal-type abutment-prosthesis connection system has been developed. Although it is proving its usefulness in single restorations, its use in multiple restorations compared to traditional systems has not been studied.

Therefore, taking into account all of the above, the present study has the overall objective of analyzing marginal bone loss (MBL) and adaptation of soft tissues by comparing a multiple prosthesis system of the "external, flat" type versus an external system of the "internal, conical" type.

Being tested
Connect®, Multi-unit
Medical subject headings
Jaw, Edentulous, Partially

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Connect®Device

    Restoration of multiple implants with a Connect® abutment between the implant and the prosthesis.

  • Multi-unitDevice

    Restoration of multiple implants with a conventional multi-unit abutment between the implant and the prosthesis.

Study groups in NCT05883202
Study groupRoleWhat they receive
Connect®ExperimentalRestoration of multiple implants with a Connect® abutment between the implant and the prosthesis.
Receives: Device: Connect®
Multi-unitActive comparatorRestoration of multiple implants with a conventional multi-unit abutment between the implant and the prosthesis.
Receives: Device: Multi-unit

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Marginal bone level

    Peri-implant marginal bone level measured by standardized periapical radiography

    Measured: 1 year

Secondary outcomes (2)
  1. Peri-implant microbiome

    Relative abundance of microbial species in the peri-implant sulcus evaluated by next-generation sequencing methods

    Measured: 1 year

  2. Peri-implant inflammation

    Concentration of pro-inflammatory markers in the peri-implant sulcus evaluated by multiplex techniques methods

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 May 2023
  2. Study start10 Jul 2023
  3. Primary completionMay 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Why it stopped: No researcher available to conduct the study.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05883202
Sponsor's protocol ID
2622CEIH2022
Status last verified
May 2026
First submitted
20 May 2023
Last updated
12 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Galindo-Moreno P, Leon-Cano A, Ortega-Oller I, Monje A, Suarez F, OValle F, Spinato S, Catena A. Prosthetic Abutment Height is a Key Factor in Peri-implant Marginal Bone Loss. J Dent Res. 2014 Jul;93(7 Suppl):80S-85S. doi: 10.1177/0022034513519800. Epub 2014 Mar 12.

    PubMed 24621670
  • Couso-Queiruga E, Tattan M, Ahmad U, Barwacz C, Gonzalez-Martin O, Avila-Ortiz G. Assessment of gingival thickness using digital file superimposition versus direct clinical measurements. Clin Oral Investig. 2021 Apr;25(4):2353-2361. doi: 10.1007/s00784-020-03558-0. Epub 2020 Aug 31.

    PubMed 32865627

Questions about this trial

What is this clinical trial studying?

A study testing Connect® and Multi-unit in people with Jaw, Edentulous, Partially, run by Universidad de Granada at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Marginal bone level (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05883202, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in